Teva Branded Pharmaceutical Products R&d, Inc.

This study tested whether monthly injections of a drug called fremanezumab could help prevent chronic migraines in children and teenagers aged 6 to 17. Researchers compared the drug to a placebo (inactive shot) in 292 participants to see if it safely reduced the number of migrain…

This study tested an investigational drug, TEV-48574, to see if it could help control two serious inflammatory bowel diseases: Crohn's disease and ulcerative colitis. For 14 weeks, 290 adults with moderate-to-severe disease received one of two doses or a placebo to see which was …

This study tested whether a drug called fremanezumab, given as a shot under the skin, could safely prevent migraines in Chinese adults. About 365 people with frequent migraines received either the drug monthly, quarterly, or a placebo for 12 weeks, followed by a period where ever…